Variant report
Variant | esv3324981 |
---|---|
Chromosome Location | chr5:12022052-12025650 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:11908684..11911495-chr5:12021242..12023652,2 | MCF-7 | breast: | |
2 | chr5:12023498..12024457-chr5:12272301..12272950,2 | MCF-7 | breast: | |
3 | chr5:11267303..11267987-chr5:12023685..12024349,2 | K562 | blood: | |
4 | chr5:11904640..11905448-chr5:12023254..12024388,4 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs376972240 | chr5:12022069-12022070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs11745664 | chr5:12022092-12022093 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs536891262 | chr5:12022094-12022095 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114011800 | chr5:12022098-12022099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs79475247 | chr5:12022111-12022112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553138082 | chr5:12022131-12022132 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558419324 | chr5:12022134-12022135 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577075948 | chr5:12022151-12022152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114729632 | chr5:12022178-12022179 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545322994 | chr5:12022207-12022208 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376065097 | chr5:12022317-12022318 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542631176 | chr5:12022325-12022326 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190108743 | chr5:12022337-12022338 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs77502601 | chr5:12022371-12022372 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182075277 | chr5:12022419-12022420 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529029406 | chr5:12022435-12022436 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541113303 | chr5:12022460-12022461 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148214364 | chr5:12022560-12022561 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532933576 | chr5:12022561-12022562 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551720344 | chr5:12022566-12022567 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563538202 | chr5:12022585-12022586 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530732179 | chr5:12022590-12022591 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548857415 | chr5:12022602-12022603 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140243314 | chr5:12022621-12022622 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185965889 | chr5:12022654-12022655 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs369369280 | chr5:12022684-12022685 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547054200 | chr5:12022687-12022688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs373097038 | chr5:12022688-12022689 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs4616894 | chr5:12022698-12022699 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs557240590 | chr5:12022713-12022714 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575486522 | chr5:12022750-12022751 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536547785 | chr5:12022857-12022858 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs200704120 | chr5:12022876-12022877 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs78731685 | chr5:12022910-12022911 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573371184 | chr5:12022956-12022957 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs377420290 | chr5:12022975-12022976 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188723006 | chr5:12023016-12023017 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs116698987 | chr5:12023024-12023025 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs563422419 | chr5:12023094-12023095 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559929005 | chr5:12023103-12023104 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs370302350 | chr5:12023137-12023138 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs577726140 | chr5:12023184-12023185 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs78482820 | chr5:12023210-12023211 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs563577334 | chr5:12023245-12023246 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531935969 | chr5:12023286-12023287 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530873333 | chr5:12023299-12023300 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs11384783 | chr5:12023306-12023307 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs398108607 | chr5:12023314-12023315 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs199869710 | chr5:12023315-12023316 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549249760 | chr5:12023316-12023317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
renal disease | 17924346 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cri-du chat syndrome | 16773131 | CNVD |
Cryptorchidism | 21048976 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cervical cancer | 16585170 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Cri-du chat syndrome | 22470819 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Schizophrenia | 18940311 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Mental retardation | 17847001 | CNVD |
Neurocytoma | 17123091 | CNVD |
Mental retardation | 19546859 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Williams Syndrome | 20824207 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:12020200-12023400 | Weak transcription | Fetal Intestine Large | intestine |
2 | chr5:12022000-12024000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr5:12022200-12023800 | Enhancers | Liver | Liver |
4 | chr5:12023400-12023800 | Enhancers | Fetal Intestine Large | intestine |